Table 3 |
|||||||
|
Hemodynamic readings taken throughout the four stages of measurement |
|||||||
|
Stage 1 |
Stage 2 |
P2,1 |
Stage 3 |
P3,1 |
Stage 4 |
P4,1 |
|
|
|
|||||||
|
Responders |
|||||||
|
SV (ml) |
68 ± 25 |
82 ± 30 |
0.001 |
70 ± 26 |
0.76 |
86 ± 31 |
0.004 |
|
SV % change from stage 1 |
21.0 ± 12.5 |
2.4 ± 7.8 |
26.3 ± 14.2 |
||||
|
CO (L/min) |
6.8 ± 2.5 |
8.0 ± 2.8 |
0.03 |
6.9 ± 2.6 |
0.89 |
8.3 ± 3.1 |
0.009 |
|
FTc (ms) |
363 ± 70 |
380 ± 68 |
0.22 |
356 ± 59 |
0.62 |
393 ± 66 |
0.03 |
|
MAP (mmHg) |
68 ± 13 |
72 ± 11 |
0.11 |
70 ± 11 |
0.41 |
71 ± 16 |
0.38 |
|
Heart rate (beats/min) |
101 ± 20 |
99 ± 21 |
0.64 |
100 ± 21 |
0.81 |
99 ± 20 |
0.61 |
|
Pulse pressure (mmHg) |
42 ± 14 |
45 ± 14 |
0.23 |
45 ± 13 |
0.30 |
49 ± 16 |
0.02 |
|
CVP (mmHg) |
7.8 ± 4.9 |
9.9 ± 3.9 |
0.10 |
||||
|
Non-responders |
|||||||
|
SV (ml) |
87 ± 30 |
91 ± 33 |
0.58 |
88 ± 30 |
0.99 |
90 ± 31 |
0.62 |
|
SV % change from stage 1 |
3.2 ± 10.4 |
0.3 ± 5.9 |
3.5 ± 8.6 |
||||
|
CO (L/min) |
8.0 ± 2.9 |
8.4 ± 3.5 |
0.46 |
7.9 ± 2.9 |
0.97 |
8.2 ± 3.1 |
0.71 |
|
FTc (ms) |
398 ± 66 |
404 ± 78 |
0.66 |
399 ± 68 |
0.89 |
405 ± 68 |
0.58 |
|
MAP (mmHg) |
74 ± 14 |
74 ± 16 |
0.95 |
73 ± 14 |
0.72 |
74 ± 16 |
0.97 |
|
Heart rate (beats/min) |
93 ± 20 |
94 ± 21 |
0.84 |
93 ± 20 |
0.91 |
92 ± 20 |
0.75 |
|
Pulse pressure (mmHg) |
48 ± 15 |
49 ± 17 |
0.97 |
49 ± 18 |
0.89 |
49 ± 19 |
0.83 |
|
CVP (mmHg) |
8.1 ± 4.8 |
11.3 ± 5.5 |
0.01 |
||||
|
|
|||||||
|
Except for the comparison of the stage 1 and 4 CVP, the Bonferroni adjusted level of significance for all P values shown is 0.01. CO = cardiac output; CVP = central venous pressure; FTc = corrected flow time; MAP = mean arterial pressure; SV = stroke volume. |
|||||||
|
Thiel et al. Critical Care 2009 13:R111 doi:10.1186/cc7955 |
|||||||